Getinge Group Interim report January – June 2014

Regulatory News:

(STO:GETIB)

Reporting period January – June

-- Order intake rose 1.2% to SEK 12,628 M (12,483), and declined 0.1% organically

-- Net sales increased by 2.4% to SEK 11,959 M (11,680), and grew 1.0% organically

-- The result before tax declined 89.0% to SEK 97 M (878)

-- Net profit declined 88.9% to SEK 71 M (641)

-- Earnings per share declined 89.1% to SEK 0.29 (2,67)

-- EBITA before restructuring costs declined 12.4% to SEK 1,575 M (1,797)

-- Cash flow from operating activities increased 10.8% to SEK 1,339 M (1,209)

Reporting period April – June

-- Order intake rose 2.1% to SEK 6,651 M (6,515), and declined 0.5% organically

-- Net sales increased by 5.2 % to SEK 6,327 M (6,016), and grew 2.3% organically

-- The result before tax declined 12.3% to SEK 549 M (626)

-- EBITA before restructuring costs declined 9.9% to SEK 905 M (1,004)

Second quarter of 2014

Despite a challenging quarter, the Group takes a confident view of the future. The weak demand situation experienced in the emerging markets at the beginning of the year is expected to improve during the remainder of the year. Specific action plans are in place to address the areas that are obstructing profit development: the quality management system within Medical Systems, a ventilator offering adapted to the needs of the emerging markets, and an adaptation of TSS (Therapeutic Support Systems) to prevailing market conditions. In addition to these short-term priorities, there are favorable opportunities to enhance the efficiency of the business and strengthen profitability in the medium term.

Teleconference with CEO Johan Malmquist and CFO Ulf Grunander

15 July 2014 at 10:00 a.m. Swedish time

Sweden: +46 (0) 8 5065 3938

UK: +44 (0) 20 3427 1907

US: +1 646 254 3365

Code: 9813592

http://mb.cision.com/Main/942/9616714/266907.pdf

This information was brought to you by Cision http://news.cision.com